top of page
OA Hero 1 advocacy v4 Screens FINAL.jpg

Theranostics Across Different Cancer Types

Theranostics is already helping transform care for selected patients with several cancer types and continues to be explored across a growing range of diseases.

Discover Where Theranostics Is Making a Difference

While its role varies depending on the cancer type, theranostics combines advanced diagnostic imaging with targeted radionuclide therapies to support more personalised approaches to patient care.

This page provides an overview of where theranostics is currently being used, where research is ongoing and where you can find trusted information about specific cancers.

If you have questions about your individual circumstances, treatment options or eligibility for theranostic approaches, please speak with your healthcare team.

Theranostic and targeted radionuclide approaches are established or available across several cancers, including prostate cancer, neuroendocrine tumours, thyroid cancer and selected non-melanoma skin cancers, with the nature and maturity of these approaches varying by cancer type.

Emerging Areas of Research

While some approaches remain investigational, ongoing clinical studies continue to expand understanding of where theranostics may contribute to future patient care.

Researchers are currently investigating the potential role of theranostics across a growing range of cancers, including:

  • Breast cancer

  • Lung cancer

  • Brain cancer

  • Ovarian cancer

  • Pancreatic cancer

  • Colorectal cancer

  • Melanoma

  • Multiple myeloma

Frequently Asked Questions

Continue Exploring

Medical Disclaimer
The information provided on this website is intended for educational purposes only and should not be considered medical advice. Treatment decisions should always be made in consultation with qualified healthcare professionals who can consider individual circumstances and clinical needs.

bottom of page